PUBLISHER: Grand View Research | PRODUCT CODE: 2018247
PUBLISHER: Grand View Research | PRODUCT CODE: 2018247
The global enteral feeding devices market size was estimated at USD 4.62 billion in 2025 and is projected to reach USD 7.19 billion by 2033, growing at a CAGR of 5.86% from 2026 to 2033. The growing geriatric population has resulted in increased incidences of diabetes, severe pancreatitis, and other gastrointestinal diseases, which fuel the market growth.
Adoption of the "Feed Early Enteral Diet Adequately for Maximum Effect" (FEED ME) protocol in surgical trauma ICUs in the U.S. enables subsidies on these devices. Technological advancements, such as the introduction of tri-funnel replacement G-tubes and J-tubes with reverse-balloon designs, are also expected to drive the growth of the enteral feeding devices industry during the forecast period.
According to the 2022 data published by the Parkinson's Foundation, the prevalence of Parkinson's disease and other neurological disorders is rising significantly with age, with more than 10 million people worldwide currently living with Parkinson's disease. About 90,000 new cases are diagnosed annually in the U.S as the global elderly population continues to grow, from around 1 billion people aged 60 years and above in 2020 to nearly 1.4 billion by 2030 and projected to reach about 2.1 billion by 2050. Older adults are particularly vulnerable to conditions such as stroke, depression, and dementia, which heighten the risk of malnutrition and frailty due to age-related changes in muscle mass and body composition. These health complications often reduce the ability of elderly individuals to perform Activities of Daily Living (ADLs), thereby increasing the likelihood of falls, injuries, and the need for long-term care support.
The rising prevalence of chronic disease is one of the major factors driving the demand for enteral feeding devices. There has been a constant increase in the prevalence of chronic diseases, such as Alzheimer's disease, Attention Deficit Hyperactivity Disorder (ADHD), osteoporosis, osteoarthritis, central nervous system disorders, and other diseases, which require clinical dietary management. These devices are highly adopted by the geriatric population who are dealing with chronic conditions for proper intake of nourishment and, thus, fueling the market growth.
According to the November 2023 estimates published by the Centers for Disease Control and Prevention, nearly six in ten adults are living with at least one chronic condition. The increasing prevalence of long-term illnesses such as gastrointestinal disorders, neurological diseases, and cancer has significantly raised the number of hospitalizations and surgical procedures worldwide. This trend is driving higher demand for enteral feeding devices, as these systems are widely used to provide nutritional support to patients unable to consume food orally. In addition, the growing geriatric population, rising incidence of critical care admissions, and increasing preference for home-based nutritional therapy are further accelerating the adoption of enteral feeding devices across hospitals, long-term care facilities, and home healthcare settings.
Global Enteral Feeding Devices Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global enteral feeding devicesmarket report based on product, age group, indication, end use, and region: